NCT05140941 - Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Hepatitis C, ChronicPregnancy; Infection

Interventions

DRUG

Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet

One Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet taken once daily for 84 days.

Trial Locations (8)

RECRUITING

University of Pittsburgh, Magee Womens Hospital, Pittsburgh

RECRUITING

Marshall University, Huntington

RECRUITING

The Ohio State University Wexner Medical Center, Columbus

ACTIVE_NOT_RECRUITING

The Christ Hospital, Cincinnati

RECRUITING

University of Utah, Salt Lake City

RECRUITING

Victoria Hospital, London Health Sciences Center, London

RECRUITING

University Health Toronto, St Michaels Hospital, Toronto

RECRUITING

Toronto General Hospital, University Health Network, Toronto